ABUS vs PH
Arbutus Biopharma Corp (ABUS) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the ABUS and PH stock pages for the full models.
Not investment advice.